Treatment of infectious diarrhea in children

Pediatric Drugs

Volumn 5, Issue 3, 2003, Pages 151-165

  Alam, Nure H ^a,b   Ashraf, Hasan ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b ICDDRB Clinical Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ACETORPHAN; AMPICILLIN; ANTIDIARRHEAL AGENT; ANTIPARASITIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DIPHENOXYLATE; DOXYCYCLINE; ERYTHROMYCIN; FOLIC ACID; FURAZOLIDONE; INFUSION FLUID; LOPERAMIDE; METRONIDAZOLE; MINERAL; NALIDIXIC ACID; NORFLOXACIN; ORAL REHYDRATION SOLUTION; PIVMECILLINAM; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RINGER LACTATE SOLUTION; SHORT CHAIN FATTY ACID; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG; VITAMIN; ZINC;

ABDOMINAL DISTENSION; AMEBIASIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BODY WEIGHT; BREAST FEEDING; CAMPYLOBACTER JEJUNI; CHOLERA; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; CRYPTOSPORIDIUM; DEHYDRATION; DEVELOPING COUNTRY; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DYSENTERY; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; FEEDING; GIARDIASIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOTHERAPY; INFECTION RISK; MAINTENANCE THERAPY; MEDICAL ASSESSMENT; NEUROTOXICITY; NONHUMAN; NUTRITION; ORAL REHYDRATION THERAPY; PARALYTIC ILEUS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; SALMONELLOSIS; SHIGELLOSIS; TREATMENT INDICATION; VIBRIO CHOLERAE;

EID: 0037234737     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305030-00002     Document Type: Review

References (99)

1. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ 1982; 60 (4): 605-13
2. Victora CG, Bryce J, Fontaine O, et al. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78 (10): 1246-55
3. Fine KD, Krejs GJ, Fordtran JS. Diarrhoea. In: Steisenger MH, Fordtran JS, editors. Gastrointestinal disease: pathophysiology diagnosis management. 4th ed. Vol. 1. Philadelphia (PA): WB Saunders, 1989; 290-316
4. Rodriguez WJ, Kim HW, Brandt CD, et al. Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. Am J Dis Child 1980; 134 (8): 777-9
5. Fishman PH. Mechanism of action of cholera toxin: events on the cell surface. In: Field M, Fordtran JS, Schultz SG, editors. Secretory diarrhoea. Bethesda (MD): American Physiological Society, 1980; 85-106
6. Alam NH, Majumder RN, Fuchs GJ. The efficacy and safety of a reduced osmolarity oral rehydration solution in adults with cholera. CHOICE Study Group. Lancet 1999; 354 (91175): 296-9
7. CHOICE Study Group. Multicenter, ranzomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhoea. Pediatrics 2001; 107 (4): 613-8
8. Treatment of diarrhoea: a manual for physicians and other senior health workers. Geneva: World Health Organization, 1990. Report no. WHO/CDR/SER/95.3
9. Guarino A, Albano F. Guidelines for the approach to outpatient children with acute diarrhoea. Acta Paediatr 2001; 90 (10): 1087-95
10. Zodpey SP, Deshpande SG, Ughade SN, et al. Risk factors for development of dehydration in children aged under five who have acute watery diarrhoea: a case control study. Public Health 1998; 112 (4): 233-6
11. Faruque ASG, Mahalanabis D, Islam A, et al. Common diarrhoeal pathogens and the risk of dehydration in young children with acute watery diarrhoea: a case control study. Am J Trop Med Hyg 1993; 49 (1): 93-100
12. Programme for the control of diarrhoeal disease: a manual for the treatment of diarrhoea for use by physicians and other senior health workers. Geneva: World Health Organization, 1990. Report no. WHO/CDD/SER/80.2 Rev. 2
13. Reduced osmolarity oral rehydration salts (ORS) formulation: a report from a meeting of experts jointly organized by UNICEF and WHO, Unicef House, New York, USA, on 18 July 2001. Geneva: World Health Organization, Child and Adolescent Health and Development, 2001. Report no. WHO/FCH/CAH/01.22
14. Ahmed T, Ali M, Ullah MM, et al. Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol. Lancet 1999; 353 (9168): 1919-22
15. Ahmed T, Begum B, Badiuzzaman AM, et al. Management of severe malnutrition and diarrhoea. Indian J Pediatr 2001; 68 (1): 45-51
16. Cash RA, Toha KM, Nalin DR, et al. Acetate in the correction of acidosis secondary to diarrhoea. Lancet 1969; II (761): 302-3
17. Molla A, Molla AM, Sarker SA, et al. Whole-gut transit time and its relationship to absorption of macronutrients during diarrhoea and after recovery. Scand J Gastroenterol 1983; 18 (4): 537-43
18. Roy SK, Haider R, Akbar MS, et al. Persistent diarrhoea: clinical efficacy and nutrient absorption with a rice-based diet. Arch Dis Child 1990; 65 (3): 294-7
19. Rees L, Brook CG. Gradual reintroduction of full strength milk after acute gastroenteritis in children. Lancet 1979; I (8119): 770-1
20. Brown KH, Gastanaduz AS, Saavedra JM. Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhoea in children. J Pediatr 1998; 112: 191-200
21. Readings on diarrhoea: students manual. Dhaka: Director General of Health Services, Ministry of Health and Family Welfare, Government of Bangladesh, 1994: 45
22. Mazumder RN, Ashraf H, Hoque SS, et al. Effect of an energy-dense diet on the clinical course of acute shigellosis in undernourished children. Br J Nutr 2000; 84: 775-9
23. Bennish M, Eusof A, Kay B, et al. Multi-resistant shigella infections in Bangladesh [letter]. Lancet 1985; II: 441
24. Tong MJ, Martin DG, Cunningham JJ, et al. Clinical and bacteriological evaluation of antibiotic treatment in shigellosis. JAMA 1970; 214: 1841-4
25. Salam MA, Bennish ML. Therapy for shigellosis: randomized double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988; 113: 901-7
26. Bennish ML, Salam MA, Hossain MA, et al. Antimicrobial resistance of shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis 1992; 14 (5): 1055-60
27. Munshi MH, Sack DA, Haider K, et al. Plasmid-mediated resistance to nalidixic acid in shigella dysenteriae type 1. Lancet 1987; II: 419-21
28. Ashkenazi S, Cleary TG, Pickering LK. Bacterial toxins associated with diarrhoeal disease. In: Lebenthal E, Duffey ME, editors. Textbook of secretory diarrhoea. New York: Raven Press Ltd, 1990: 255-72
29. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5 (5): 607-25
30. Kiessling CR, Cutting JH, Loftis M, et al. Antimicrobial resistance of food-related salmonella isolates 1999-2000. J Food Prot 2002; 65 (4): 603-8
31. Rigothier MC, Khun H, Tavares P, et al. Fate of entamoeba histolytica during establishment of amoebic liver abscess analyzed by quantitative radio imaging and histology. Infect Immun 2002; 70 (6): 3208-15
32. Bruchhaus I, Roeder T, Lotter H, et al. Differential gene expression in entamoeba histolytica isolated from amoebic liver abscess. Mol Microbiol 2002; 44 (4): 1063-72
33. Shamsuzzaman SM, Hashiguchi Y. Thoracic amoebiasis. Clin Chest Med 2002; 23 (2): 479-92
34. Kulkarni H, Goldwater PN, Martin A, et al. Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients. Comp Immunol Microbiol Infect Dis 2002; 25 (4): 249-68
35. Persistent diarrhoea in children in developing countries: memorandum from a WHO meeting. Bull World Health Organ 1988; 66 (6): 709-17
36. Back RE, Brown KH, Becker S. Malnutrition is a determining factor in diarrhoeal duration, but not incidence, among young children in a longitudinal study in rural Bangladesh. Am J Clin Nutr 1984; 39 (1): 87-94
37. Wallen-Smith JA, Nazar H, Manuel P, et al. Protein intolerance as a cause of postentenitis diarrhoea. In: Lebenthal E, editor. Chronic diarrhoea in children. New York: Raven Press, 1984: 407-23
38. International Working Group on Persistent Diarrhoea. Evaluation of an algorithm for the treatment of persistent diarrhoea: a multicentre study. Bull World Health Organ 1996; 74 (5): 479-89
39. Ashraf H, Ahmed S, Fuchs GJ, et al. Persistent diarrhoea: associated infection and response to a low lactose diet. J Trop Pediatr 2002; 48: 142-8
40. Management of the child with a serious infection or severe malnutrition. Geneva: World Health Organization, 2000
41. The rational use of drugs in the management of acute diarrhoea in children. Geneva: World Health Organization, 1990: 12
42. Dupont HL, Hornick RB. Adverse effect of lomotil therapy in shigellosis. JAMA 1973 Dec; 226 (13): 1525-8
43. Curtis JA, Goel KM. Lomotil poisoning in children. Arch Dis Child 1979; 54 (3): 222-5
44. Rumack BH, Temple AR. Lomotil poisoning. Pediatrics 1974; 53 (4): 495-500
45. Kassem AS, Madkour AA, Massoud BZ, et al. Loperamide in acute childhood diarrhoea: a double blind controlled trial. J Diarrhoeal Dis Res 1983; 1 (I): 10-6
46. Karrar ZA, Abdullah MA, Moody JB, et al. Loperamide in acute diarrhoea in childhood: results of a double blind, placebo controlled clinical trial. Ann Trop Paediatr 1987; 7 (2): 122-7
47. Diarrhoeal Disease Study Group. Loperanmide in acute diarrhoea in childhood: results of double blind, placebo controlled multicentre clinical trial. BMJ 1984; 289: 1263-7
48. Murtaza A, Khan SR, Butt KS, et al. Paralytic ileus: a serious complication in acute diarrhoeal disease among infants in developing countries. Acta Paediatr Scand 1989; 78 (5): 701-5
49. Bhutta TI, Tahir KI. Loperamide poisoning in children [letter]. Lancet 1990; 335: 363
50. Minton NA, Henry JA. Loperamide poisoning in children [letter]. Lancet 1990; 335: 788
51. Smith PL, Field M. In vitro anti-secretory effects of trifluoperazine and other neuroleptics in rabbit and human small intestine. Gastroenterology 1980; 78 (6): 1545-53
52. Holmgren J, Lange S, Lonnroth I. Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine. Gastroenterology 1978; 75 (6): 1103-8
53. Lonnroth I, Holmgren J, Lange S. Chlorpromazine inhibits cholera toxin-induced intestinal hypersecretion. Med Biol 1977; 55 (3): 126-9
54. Rabbani GH, Greenough III WB, Holmgren J, et al. Chlorpromazine reduces fluid loss in cholera. Lancet 1979; 1: 410-2
55. Rabbani GH, Butler T, Bardhan PK, et al. Reduction of fluid loss in cholera by nicotinic acid: a randomized controlled trial. Lancet 1983; II (8365-66): 1439-42
56. Islam A, Bardhan PK, Islam MR, et al. A randomized double blind trial of aspirin versus placebo in cholera and non-cholera diarrhoea. Trop Geogr Med 1986; 38 (3): 221-5
57. Rabbani GH, Butler T. Indomethacin and chloroquine fail to inhibit fluid loss in cholera. Gastroenterology 1985; 89 (5): 1035-7
58. Molla AM, Gyr K, Bardhan PK, et al. Effect of intravenous somatostatin on stool output in diarrhoea due to vibrio cholera. Gastroenterology 1985; 87 (4): 845-7
59. Primi MP, Bueno L, Baumer P, et al. Racecadotril demonstrates intestinal anti-secretory activity in vivo. Aliment Pharmacol Ther 1999; 13 Suppl. 6: 3-7
60. Krejs GJ. Acetorphan prevents cholera toxin induced water and electrolyte secretion in the human jejunum. Gastroenterology 1979; 9: 887-91
61. Bergmann JF, Chaussade S, Couturier D, et al. Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers. Aliment Pharmacol Ther 1992; 6 (3): 305-13
62. Hamza H, Ben Khalifa H, Baumer P, et al. Racecadotril versus placebo in the treatment of acute diarrhoea in adults. Aliment Pharmacol Ther 1999; 13 Suppl. 6: 15-9
63. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, et al. Racecadotril in the treatment of acute diarrhoea in children. N Engl J Med 2000; 343: 463-7
64. Cezard JP, Duhamel JF, Meyer M, et al. Efficacy and tolerability of racecadotril in acute diarrhoea in children. Gastroenterology 2001; 120: 799-805
65. Sarker SA, Casswall TH, Mahlanabis D, et al. Successful treatment of rotavirus diarrhoea in children with immunoglobulin from immunized bovine colostrums. Pediatr Infect Dis J 1998; 17: 1149-54
66. Sarker SA, Casswall TH, Juneja LR, et al. Randomized, placebo-controlled clinical trial of hyperimmunized chicken egg yolk immunuglobulin in children with rotavirus diarrhoea. J Pediatr Gastroenterol Nutr 2001; 32: 19-25
67. Mitra AK, Mahalanabis D, Ashraf H, et al. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double blind, controlled clinical trial. Acta Pediatr 1995; 84: 996-1001
68. Casswall TH, Sarkar SA, Faruque SM, et al. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobin milk concentrate from hyperimmunised cows: a double blind, placebo controlled, clinical trial. Scand J Gastroenterol 2000; 35 (7): 711-8
69. Ashraf H, Mitra AK, Mahalanabis D, et al. Hyperimmune bovine colostrums in the treatment of shigellosis in children: a double blind, randomized, controlled trial. Acta Pediatr 2001; 90: 1-6
70. Brussow H, Hilpert H, Walther I, et al. Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol 1987; 25 (6): 982-6
71. Guarino A, Casola A, Bruzzese E, et al. Human serum immunoglobulin counteracts rotaviral infection in Caco-2 cells. Pediatr Res 1996; 40 (6): 881-7
72. Salminen S, Bouley C, Boutron Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 Suppl. 1: S147-71
73. Raza S, Graham SM, Allen SJ, et al. Lactobacillus GG promotes recovery from acute non-bloody diarrhoea in Pakistan. Pediatr Infect Dis J 1995; 14 (2): 107-11
74. Isolauri E, Juntunen M, Rautanen T, et al. A human lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhoea in children. Pediatrics 1991; 88: 90-7
75. Shornikova AV, Cassa IA, Mykkanen H, et al. Bacteriotherapy with lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16 (12): 1103-7
76. Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhoea. J Pediatr Gastroenterol Nutr 1997; 25 (5): 516-9
77. Colombel JF, Cortot A, Neut C, et al. Yoghurt with bifdobacterium longum reduces erythromycin-induced gastrointestinal effects [letter]. Lancet 1987; II (8549): 43
78. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22 (1): 57-9
79. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 1992; 32 (2): 41-2
80. Cummings JH, Englyst HN. Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 1987; 45 Suppl. 5: 1243-55
81. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982; 83 (2): 424-9
82. Sakata T. Effects of indigestible dietary bulk and short chain fatty acids on the tissue weight and epithelial cell proliferation rate of the digestive tract in rats. J Nutr Sci Vitaminol (Tokyo) 1986; 32 (4): 355-62
83. Roediger WE, Rae DA. Trophic effect of short chain fatty acids on mucosal handling of ions by the defunctioned colon. Br J Surg 1982; 69 (1): 23-5
84. McNeil NI, Cummings JH, James WP. Short-chain fatty acid absorption by the human large intestine. Gut 1978; 9: 819-22
85. Ruppin H, Bar-Meier S, Soergel KH. Absorption of short-chain fatty acids (SCFAs) by the colon. Gastroenterology 1980; 78 (6): 1500-7
86. Argenzio RA, Miller N, Von Engelhardt W. Effect of volatile fatty acids on water and ion absorption from the goat colon. Am J Physiol 1975; 229 (4): 997-1002
87. Roediger WE, Moore A. Effect of short-chain fatty acids on sodium absorption in isolated human colon perfused through vascular bed. Dig Dis Sci 1981; 26 (2): 100-6
88. Binder HJ, Mehta P. Short chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon. Gastroenterology 1989; 96 (4): 989-96
89. Ramakrishna BS, Mathan VI. Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids. Gut 1993; 34 (9): 1215-8
90. Speelman P, Butler T, Kabir I, et al. Colonic dysfunction during cholera infection. Gastroenterology 1986; 91 (5): 1164-70
91. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304 (6822): 287-91
92. Ramakrishna BS, Venkataraman S, Srinivasan P, et al. Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med 2000; 342 (5): 308-13
93. Alam NH, Meier R, Scheinder H, et al. Partially hydrolyzed guar gum supplemented oral rehydration solution in the treatment of acute diarrhoea in children. J Pediatr Gastroenterol Nutr 2000; 31: 503-57
94. Alam NH, Meier RF, Sarker SA, et al. Evaluation of the effect of a soluble fiber (Benefiber) supplemented comminuted chicken based diet in the treatment of persistent diarrhoea. Gastroenterology 2001; 120 Suppl. 1: A-1111
95. Rabbani GH, Teka T, Zaman B, et al. Clinical studies in persistent diarrhoea: dietary management with green banana or pectin in Bangladesh children. Gastroenterology 2001; 121 (3): 554-60
96. Fontaine O. Effect of zinc supplementation on clinical course of acute diarrhoea. J Health Popul Nutr 2001; 19 (4): 339-46
97. Haffejee IE. Effect of oral folam on duration of acute diarrhoea. Lancet 1988; II: 334-5
98. Haffejee IE. Folate for diarrhoea. Dialogue Diarrhoea 1990; 43: 2
99. Ashraf H, Rahman MM, Fuchs GJ, et al. Folic acid in the treatment of acute watery diarrhoea in children: a double-blind, randomized, controlled trial. Acta Paediatr 1998; 87: 1113-5